Market Value: immunome.com (IMNM)
This daily price chart for Immunome, Inc. (IMNM) on the GURU.Markets platform, where the market capitalization stands at 2.13, confirms the effective synergy between precise biomaterial delivery and the development of targeted ADC drugs for cancer treatment. The business relies on cutting-edge scientific research in radioligands, as well as close collaboration with global biotech leaders to create new tumor therapy methods.
Comprehensive metric breakdowns and analytics for Immunome Bio (IMNM)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book value of equity indicators:
- company total debt and liquidity indicators:
Total Debt to Capital Immunome, Inc.|IMNM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Immunome, Inc.|IMNM - Company Aggregate Debts|Debt to Book Capitalization Ratio Immunome Bio|IMNM - Company Long-Term Loans and Borrowings|Company Short-Term Debt Immunome|Quick Ratio immunome.com
- business earnings and investment ratios data:
IMNM - Net Profit|Future Profit Immunome, Inc.|IMNM - Company Value to Net Income|Forward P/E Multiple Immunome Corp|IMNM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunome Bio|IMNM - Operating profit before deduction of amortization|Earnings per share for the last twelve months Immunome|IMNM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months immunome.com|IMNM - Earnings growth in current year|Net earnings per share growth forecast for next year Immunome, Inc.
- sales and revenue data:
Fundamental company analysis:IMNM (Immunome)
The prospects of Immunome, Inc. (IMNM) depend on the efficiency of antibody development rather than market cycles, making the cost of capital sensitive to R&D success. Analyzing the issuer's market capitalization, which currently stands at 2.13, an investor sees the product of the current share price and the volume of shares, allowing for the rapid identification of asset overvaluation or fundamental insufficiency.
Key competitors
Market Value argenx ARGX|BNTX - Market Valuation|ABVX - Market Value|ADMA (ADMA Corp) - Market Capitalization|Protagonist Therapeutics (PTGX) - Market Value|Market Valuation immunovant.com|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|Market Capitalization Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics (KYTX) - Market Value|Market Valuation tizianalifesciences.com|Market Value Cabaletta Bio|Market Valuation Ventyx Biosciences Inc. (VTYX)|Market Valuation THTX (Theratechnologies Inc)|Market Capitalization Avalo Therapeutics Inc (AVTX)|Market Value Eledon Pharmaceuticals ELDN|AGEN: Market Capitalization|CLYM - Market Value|Market Value zurabio.com|aTyr (ATYR) - Market Value|Market Valuation Adagene Inc.|IMA (ImageneBio) - Market Capitalization|Market Value Shattuck Therapeutics STTK|Market Valuation EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Market Value|Market Capitalization IMUX (Immunic)|Market Capitalization Atara Biotherapeutics, Inc. (ATRA)|IFRX - Market Value|XFOR (x4pharma.com) - Market Capitalization|ACET: Market Capitalization|Market Valuation Celularity|Market Valuation INMB|Barinthus Biotherapeutics Corp (BRNS) - Market Capitalization|Market Capitalization KZR|Market Capitalization sabbiotherapeutics.com|Market Value Akari Therapeutics Plc AKTX|ENLV - Market Valuation|QTTB - Market Value|GOVX (GeoVax Corp) - Market Capitalization|Edesa Biotech, Inc. (EDSA) - Market Value|Market Valuation ibioinc.com|Market Value Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd - Market Valuation|Market Capitalization BOLT|HCWB (hcwbiologics.com) - Market Value|Market Capitalization APVO (Aptevo Therapeutics Inc.)|Market Capitalization aimimmuno.com AIM|ADTX - Market Value|Market Value GRI (GRI Bio Inc)|XORTX (XRTX) - Market Value|Market Valuation Vyome Therapeutics|REVB (Revelation Biosciences) - Market Capitalization|Market Capitalization indaptusrx.com|Market Valuation SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Market Value|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc (ALLK)|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation Ocean Biomedical Inc|Market Valuation TCBP|Market Capitalization Third Harmonic Bio Inc
